Julia Moody
Impact in
-
- Antibiotic Use and Resistance
- Clinical Biochemistry top 0.5%
- Bacterial Identification and Susceptibility Testing
Papers in
-
- Antibiotic Use and Resistance 9
-
- Bacterial Identification and Susceptibility Testing 24
- Co-authors
- Bert F. WoolfreyEdward SeptimusJason HickokJonathan B. PerlinDale N. GerdingSusan S. HuangLance R. PetersonKen Kleinman
- Journals
- Antimicrobial Agents and Chemotherapy (9 papers)Infection Control and Hospital Epidemiology (8 papers)American Journal of Infection Control (4 papers)Diagnostic Microbiology and Infectious Disease (4 papers)Journal of Antimicrobial Chemotherapy (3 papers)
- Partner nations
- United StatesUnited KingdomAustralia
In The Last Decade
Julia Moody
52 papers receiving 2.1k citations
Hit Papers
Peers
Comparison fields: 5 of 129
- Applied Microbiology and Biotechnology 329
- Clinical Biochemistry 460
- Molecular Medicine 306
- Infectious Diseases 1.1k
- Critical Care and Intensive Care Medicine 290
Countries citing papers authored by Julia Moody
This map shows the geographic impact of Julia Moody's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julia Moody with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julia Moody more than expected).
Fields of papers citing papers by Julia Moody
This network shows the impact of papers produced by Julia Moody. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julia Moody. The network helps show where Julia Moody may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Julia Moody, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 52 | |
| 3 | 2023 | 7 | |
| 4 | 2023 | 2 | |
| 5 | 2018 | 26 | |
| 6 | 2018 | 11 | |
| 7 | 2014 | 21 | |
| 8 | 2014 | 19 | |
| 9 | Targeted versus Universal Decolonization to Prevent ICU Infection Hit paper breakdown → | 2013 | 516 |
| 10 | 2013 | 23 | |
| 11 | 2012 | 44 | |
| 12 | 2012 | 8 | |
| 13 | 2012 | 29 | |
| 14 | 1997 | 149 | |
| 15 | 1997 | 3 | |
| 16 | 1993 | 74 | |
| 17 | 1992 | 14 | |
| 18 | 1991 | 2 | |
| 19 | 1991 | 1 | |
| 20 | 1987 | 7 |
About Julia Moody
Julia Moody is a scholar working on Applied Microbiology and Biotechnology, Clinical Biochemistry, Molecular Medicine, Infectious Diseases and Critical Care and Intensive Care Medicine, having authored 55 papers that have together received 2.3k indexed citations. Recurring topics across this work include Bacterial Identification and Susceptibility Testing (24 papers), Antimicrobial Resistance in Staphylococcus (21 papers), Antibiotic Resistance in Bacteria (13 papers), Antibiotics Pharmacokinetics and Efficacy (13 papers), Clostridium difficile and Clostridium perfringens research (11 papers), Antibiotic Use and Resistance (9 papers), Nosocomial Infections in ICU (5 papers) and Infection Control in Healthcare (3 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (329 citations), Clinical Biochemistry (460 citations), Molecular Medicine (306 citations), Infectious Diseases (1.1k citations) and Critical Care and Intensive Care Medicine (290 citations). Julia Moody has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include Bert F. Woolfrey, Edward Septimus, Jason Hickok, Jonathan B. Perlin, Dale N. Gerding, Susan S. Huang, Lance R. Peterson, Ken Kleinman, Taliser R. Avery and John A. Jernigan. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Infection Control and Hospital Epidemiology, American Journal of Infection Control, Diagnostic Microbiology and Infectious Disease and Journal of Antimicrobial Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.